Draupnir Bio ApS
Private limited companyCVR 38546880FrederiksbergActive
Draupnir Bio ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2017. The company made a loss in both 2024 and 2025, most recently DKK 12.3m. Equity fell to DKK 15.3m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
RevenueDKK 45.1m
Net profit−DKK 12.3m+69.5% vs. 2024
EquityDKK 15.3m−44.8% vs. 2024
Employees10latest month from CVR
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- The loss got smaller: from DKK 40.3m to DKK 12.3m (2024 → 2025).
- Equity fell 45% (2024 → 2025), to DKK 15.3m.
Management and owners, last 24 months
- New owners registered: INKEF Holding Coöperatief U.A. (29/06/2026).
- No longer registered as owner: Stichting Depositary INKEF Investment Fund (29/06/2026).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | 45,120 | – |
| Operating profit (EBIT) | −65,731 | −71,752 | −45,037 | −46,436 | −46,149 | −9,518 | +79.4% |
| Profit before tax | −66,120 | −72,417 | −45,486 | −46,518 | −45,743 | −14,198 | +69% |
| Net profit | −60,620 | −67,044 | −39,890 | −41,166 | −40,314 | −12,310 | +69.5% |
| Total assets | 60,790 | 67,865 | 28,383 | 36,192 | 35,033 | 39,072 | +11.5% |
| Equity | 54,225 | 53,466 | 18,566 | 29,386 | 27,633 | 15,256 | −44.8% |
| Cash and cash equivalents | 50,985 | 49,312 | 12,206 | 21,745 | 24,222 | 34,014 | +40.4% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresLoss for 6 years in a row
Net result has been negative in 2020–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
Equity fell sharply
Equity fell 45% from 2024 to 2025 (DKK 27.6m to DKK 15.3m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 04/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 27/06/2025 | The company | PDF not statedXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 15/05/2024 | The company | PDF not statedXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 12/06/2023 | The company | PDF not statedXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 10/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 21/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
EquityDKK 15.3mNo. 120 of 431
Better than 72% of the companies in the industry
Number of employees10No. 142 of 431
Better than 67% of the companies in the industry
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | not stated | No. 6,924of 69,964 Better than 90% |
| Same industry and fewer than 20 employees329 companies in the comparison | not stated | No. 50of 329 Better than 85% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | not stated | No. 2,817of 33,687 Better than 92% |
| All companies of type ApS66,508 companies in the comparison | not stated | No. 5,115of 66,505 Better than 92% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineeringGross profit
- Draupnir Bio ApS–
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
Net profit
- Draupnir Bio ApS−DKK 12.3m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
Equity
- Draupnir Bio ApSDKK 15.3m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
Employees
- Draupnir Bio ApS10
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterOwners
- MP Healthcare Venture Management, Inc,10%
- Novo Holdings A/S20%
- Coöperatieve Gilde Healthcare IV U.A.20%
- Danmarks Eksport- og Investeringsfond10%
- INKEF Holding Coöperatief U.A.20%
Draupnir Bio ApS
Management
7 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Andrew Thomas Hotchkiss | Director | 01/06/2021 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Simon Glerup Pedersen | Board member | 23/10/2019 |
| Stefan Emanuel Luzi | Board member | 23/10/2019 |
| Robert Andrew Donald Scott | Board member | 03/09/2020 |
| Emmanuelle Coutanceau | Board member | 09/06/2021 |
| Eva-Lotta Coulter | Chair of the board | 09/06/2021 |
| Ivan Burkov | Board member | 24/02/2022 |
- Founders
- Camilla Gustafsen Consulting ApS, Peder Søndergaard Madsen Consulting ApS, Simon Glerup Consulting ApS
Former management (8)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Camilla Gustafsen | Board member | 04/04/2017 | 26/10/2018 |
| Simon Glerup Pedersen | Board member | 04/04/2017 | 26/10/2018 |
| Simon Glerup Pedersen | Director | 04/04/2017 | 01/06/2021 |
| Peder Søndergaard Madsen | Chair of the board | 04/04/2017 | 26/10/2018 |
| Emmanuelle Coutanceau | Chair of the board | 26/10/2018 | 08/06/2021 |
| Peter Hans Andreas Seeberger | Board member | 26/10/2018 | 23/10/2019 |
| Fiona MacLaughlin | Board member | 23/10/2019 | 30/04/2020 |
| Roel Bulthuis | Board member | 30/04/2020 | 24/02/2022 |
Signing rule: Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem, eller af bestyrelsesformanden i forening med en direktør eller af den samlede bestyrelse.
Address and production units
2 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Draupnir Bio ApS | Palle Juul-Jensens Boulevard 82, 8200 Aarhus N | 9 | 1027036437 |
| Draupnir Bio ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 1 | 1022336491 |
Purpose
Selskabets formål er at forske i, udvikle, producere og sælge bioteknologiske produkter og medicinalprodukter samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
The purpose is quoted from the register in Danish.
Changes year by year
96 registered events82017
72018
262019
92020
142021
42022
112023
122024
22025
32026
20263 changesownership 2 · accounts 1
- OwnershipINKEF Holding Coöperatief U.A. registered as owner (20%)
- OwnershipStichting Depositary INKEF Investment Fund is no longer registered as owner
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
202412 changescapital 2 · ownership 8 · address 1 · accounts 1
- CapitalShare capital changed from 1,151,772 DKK to 1,279,717 DKK
- OwnershipDanmarks Eksport- og Investeringsfond registered as owner (10%)
- OwnershipNovo Holdings A/S registered as owner (20%)
- OwnershipCoöperatieve Gilde Healthcare IV U.A. registered as owner (20%)
- OwnershipNovo Holdings A/S is no longer registered as owner
- OwnershipCoöperatieve Gilde Healthcare IV U.A. is no longer registered as owner
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
- AccountsAnnual report for 2023 published
- CapitalShare capital changed from 992,112 DKK to 1,151,772 DKK
- OwnershipMP Healthcare Venture Management, Inc, registered as owner (10%)
- OwnershipStichting Depositary INKEF Investment Fund registered as owner (20%)
- OwnershipStichting Depositary INKEF Investment Fund is no longer registered as owner
202311 changescapital 2 · accounts 1 · ownership 7 · industry 1
- CapitalShare capital changed from 852,567 DKK to 992,112 DKK
- AccountsAnnual report for 2022 published
- CapitalShare capital changed from 513,132 DKK to 852,567 DKK
- OwnershipNovo Holdings A/S registered as owner (25%)
- OwnershipCoöperatieve Gilde Healthcare IV U.A. registered as owner (25%)
- OwnershipStichting Depositary INKEF Investment Fund registered as owner (25%)
- OwnershipHigh-Tech Gründerfonds III GmbH & Co. KG is no longer registered as owner
- OwnershipCoöperatieve Gilde Healthcare IV U.A. is no longer registered as owner
- OwnershipStichting Depositary INKEF Investment Fund is no longer registered as owner
- OwnershipNovo Holdings A/S is no longer registered as owner
- IndustryIndustry changed to Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)
20224 changesaccounts 1 · management 2 · address 1
- AccountsAnnual report for 2021 published
- ManagementIvan Burkov appointed board member
- ManagementRoel Bulthuis stepped down as board member
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
202114 changescapital 1 · ownership 6 · address 1 · accounts 1 · management 5
- CapitalShare capital changed from 374,938 DKK to 513,132 DKK
- OwnershipCoöperatieve Gilde Healthcare IV U.A. registered as owner (25%)
- OwnershipCamilla Gustafsen Consulting ApS is no longer registered as owner
- OwnershipPeder Søndergaard Madsen Consulting ApS is no longer registered as owner
- OwnershipSimon Glerup Consulting ApS is no longer registered as owner
- OwnershipSeeberger Science GmbH is no longer registered as owner
- OwnershipCoöperatieve Gilde Healthcare IV U.A. is no longer registered as owner
- AddressMoved to Tuborgvej 5, 2900 Hellerup
- AccountsAnnual report for 2020 published
- ManagementEva-Lotta Coulter appointed chair of the board
- ManagementEmmanuelle Coutanceau appointed board member
- ManagementEmmanuelle Coutanceau stepped down as chair of the board
- ManagementAndrew Thomas Hotchkiss appointed director
- ManagementSimon Glerup Pedersen stepped down as director
20209 changesaddress 1 · management 3 · capital 1 · ownership 4
- AddressMoved to Ole Maaløes Vej 3, 2200 København N
- ManagementRobert Andrew Donald Scott appointed board member
- CapitalShare capital changed from 250,737 DKK to 374,938 DKK
- OwnershipCoöperatieve Gilde Healthcare IV U.A. registered as owner (20%)
- OwnershipStichting Depositary INKEF Investment Fund registered as owner (20%)
- OwnershipCoöperatieve Gilde Healthcare IV U.A. is no longer registered as owner
- OwnershipStichting Depositary INKEF Investment Fund is no longer registered as owner
- ManagementRoel Bulthuis appointed board member
- ManagementFiona MacLaughlin stepped down as board member
201926 changescapital 2 · management 4 · ownership 20
- CapitalShare capital changed from 81,633 DKK to 250,737 DKK
- ManagementStefan Emanuel Luzi appointed board member
- ManagementFiona MacLaughlin appointed board member
- ManagementSimon Glerup Pedersen appointed board member
- ManagementPeter Hans Andreas Seeberger stepped down as board member
- OwnershipCoöperatieve Gilde Healthcare IV U.A. registered as owner (15%)
- OwnershipNovo Holdings A/S registered as owner (25%)
- OwnershipCamilla Gustafsen Consulting ApS registered as owner (5%)
- OwnershipPeder Søndergaard Madsen Consulting ApS registered as owner (5%)
- OwnershipSimon Glerup Consulting ApS registered as owner (5%)
- OwnershipSeeberger Science GmbH registered as owner (5%)
- OwnershipStichting Depositary INKEF Investment Fund registered as owner (15%)
- OwnershipHigh-Tech Gründerfonds III GmbH & Co. KG registered as owner (5%)
- OwnershipSeeberger Science GmbH is no longer registered as owner
- OwnershipSimon Glerup Consulting ApS is no longer registered as owner
- OwnershipPeder Søndergaard Madsen Consulting ApS is no longer registered as owner
- OwnershipCamilla Gustafsen Consulting ApS is no longer registered as owner
- CapitalShare capital changed from 80,000 DKK to 81,633 DKK
- OwnershipSeeberger Science GmbH registered as owner (20%)
- OwnershipSimon Glerup Consulting ApS registered as owner (20%)
- OwnershipPeder Søndergaard Madsen Consulting ApS registered as owner (20%)
- OwnershipCamilla Gustafsen Consulting ApS registered as owner (20%)
- OwnershipSeeberger Science GmbH is no longer registered as owner
- OwnershipPeder Søndergaard Madsen Consulting ApS is no longer registered as owner
- OwnershipSimon Glerup Consulting ApS is no longer registered as owner
- OwnershipCamilla Gustafsen Consulting ApS is no longer registered as owner
20187 changesmanagement 5 · capital 1 · ownership 1
- ManagementPeter Hans Andreas Seeberger appointed board member
- ManagementEmmanuelle Coutanceau appointed chair of the board
- ManagementSimon Glerup Pedersen stepped down as board member
- ManagementPeder Søndergaard Madsen stepped down as chair of the board
- ManagementCamilla Gustafsen stepped down as board member
- CapitalShare capital changed from 60,000 DKK to 80,000 DKK
- OwnershipSeeberger Science GmbH registered as owner (25%)
20178 changesfounded 1 · management 4 · ownership 3
- FoundedRegistered as Draupnir Bio ApS
- ManagementSimon Glerup Pedersen appointed board member
- ManagementPeder Søndergaard Madsen appointed chair of the board
- ManagementSimon Glerup Pedersen appointed director
- ManagementCamilla Gustafsen appointed board member
- OwnershipPeder Søndergaard Madsen Consulting ApS registered as owner (25%)
- OwnershipSimon Glerup Consulting ApS registered as owner (25%)
- OwnershipCamilla Gustafsen Consulting ApS registered as owner (25%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Minervax ApSvia Emmanuelle Coutanceau
- Muna Therapeutics ApSvia Peder Søndergaard Madsen
- de novo foundry ApSvia Emmanuelle Coutanceau
- Antag Therapeutics ApSvia Emmanuelle Coutanceau
- Aloop Therapeutics ApSvia Emmanuelle Coutanceau
- Avilex Pharma ApSvia Emmanuelle Coutanceau
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.